TTM
69.3%
YoY change
+4.57pp
Trough year (2023)
50.9%
Peak year (1998)
88.1%
Latest annual
70.3%
Gross Margin history chart for Pfizer (PFE) from 1985 to 2025
Latest: 70.3%
Gross Margin change chart for Pfizer (PFE) from 1985 to 2025
Latest: +4.57pp
Gross Margin history table for Pfizer (PFE) from 1985 to 2025
| 2025 | 70.3% | +4.57pp | ||
| 2024 | 65.8% | +14.82pp | ||
| 2023 | 50.9% | -10.94pp | ||
| 2022 | 61.9% | +4.22pp | ||
| 2021 | 57.7% | -14.07pp | ||
| 2020 | 71.7% | +2.40pp | ||
| 2019 | 69.3% | -0.82pp | ||
| 2018 | 70.2% | +0.19pp | ||
| 2017 | 70.0% | +0.18pp | ||
| 2016 | 69.8% | -3.27pp | ||
| 2015 | 73.1% | -0.10pp | ||
| 2014 | 73.2% | +0.22pp | ||
| 2013 | 72.9% | -0.26pp | ||
| 2012 | 73.2% | +1.33pp | ||
| 2011 | 71.9% | +2.77pp | ||
| 2010 | 69.1% | -7.71pp | ||
| 2009 | 76.8% | -2.40pp | ||
| 2008 | 79.2% | +3.43pp | ||
| 2007 | 75.8% | -2.49pp | ||
| 2006 | 78.3% | +0.44pp | ||
| 2005 | 77.8% | -1.40pp | ||
| 2004 | 79.2% | +0.99pp | ||
| 2003 | 78.2% | -9.26pp | ||
| 2002 | 87.5% | +3.11pp | ||
| 2001 | 84.4% | -1.88pp | ||
| 2000 | 86.3% | -1.47pp | ||
| 1999 | 87.7% | -0.41pp | ||
| 1998 | 88.1% | +2.32pp | ||
| 1997 | 85.8% | +1.27pp | ||
| 1996 | 84.6% | +2.42pp | ||
| 1995 | 82.1% | +1.78pp | ||
| 1994 | 80.4% | +0.60pp | ||
| 1993 | 79.8% | +4.10pp | ||
| 1992 | 75.7% | +3.80pp | ||
| 1991 | 71.8% | +3.61pp | ||
| 1990 | 68.2% | +0.95pp | ||
| 1989 | 67.3% | +1.19pp | ||
| 1988 | 66.1% | +1.36pp | ||
| 1987 | 64.7% | -0.11pp | ||
| 1986 | 64.9% | +0.04pp | ||
| 1985 | 64.8% | — |
- 202570.3%+4.57pp
- 202465.8%+14.82pp
- 202350.9%-10.94pp
- 202261.9%+4.22pp
- 202157.7%-14.07pp
- 202071.7%+2.40pp
- 201969.3%-0.82pp
- 201870.2%+0.19pp
- 201770.0%+0.18pp
- 201669.8%-3.27pp
- 201573.1%-0.10pp
- 201473.2%+0.22pp
- 201372.9%-0.26pp
- 201273.2%+1.33pp
- 201171.9%+2.77pp
- 201069.1%-7.71pp
- 200976.8%-2.40pp
- 200879.2%+3.43pp
- 200775.8%-2.49pp
- 200678.3%+0.44pp
- 200577.8%-1.40pp
- 200479.2%+0.99pp
- 200378.2%-9.26pp
- 200287.5%+3.11pp
- 200184.4%-1.88pp
- 200086.3%-1.47pp
- 199987.7%-0.41pp
- 199888.1%+2.32pp
- 199785.8%+1.27pp
- 199684.6%+2.42pp
- 199582.1%+1.78pp
- 199480.4%+0.60pp
- 199379.8%+4.10pp
- 199275.7%+3.80pp
- 199171.8%+3.61pp
- 199068.2%+0.95pp
- 198967.3%+1.19pp
- 198866.1%+1.36pp
- 198764.7%-0.11pp
- 198664.9%+0.04pp
- 198564.8%—
Gross Margin values are taken from Pfizer's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Margin at Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's latest reported gross margin is 69.3%. Gross margin is gross profit divided by revenue, expressed as a percentage. It shows how much of each sales dollar survives the direct cost of goods sold — before operating expenses, interest, and taxes. A higher gross margin generally signals pricing power and production efficiency. Margins are most meaningful compared against sector peers and a company's own history.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Pfizer (PFE) reported gross margin of 70.33% – expanded 4.6 percentage points year-over-year.
88.15% stands as the all-time-high annual gross margin, posted in 1998, against a low of 50.95% during 2023.
Pfizer Gross Margin by Year
Pfizer Gross Margin 2025: 70.3%
Pfizer gross margin in 2025 was 70.33%, expanded 4.6 percentage points from 2024.
Pfizer Gross Margin 2024: 65.8%
2024's gross margin for Pfizer came in at 65.77%, expanded 14.8 percentage points from 2023.
Pfizer Gross Margin 2023: 50.9%
Pfizer posted gross margin of 50.95% in 2023, contracted 10.9 percentage points from 2022. This figure represents the lowest annual value in the available history.
Pfizer Gross Margin 2022: 61.9%
In 2022, Pfizer reported gross margin of 61.89%, expanded 4.2 percentage points from 2021.
Pfizer Gross Margin 2021: 57.7%
Pfizer gross margin in 2021 was 57.67%.
See more financial history for Pfizer (PFE).
Sector peers by Gross Margin
Healthcare peers of Pfizer (PFE), ranked by their latest gross margin
| 83.5% | |
| 81.8% | |
| 81.7% | |
| 75.9% | |
| 71.5% | |
| 70.7% | |
| 70.0% | |
| 18.8% |
- 83.5%
- 81.8%
- 81.7%
- 75.9%
- 71.5%
- 70.7%
Frequently asked questions
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation